Nicole Roth

Stuttgart, BW 70599, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Enzymatic Deamidation of Plant Proteins by Protein-Glutamine Glutaminases: Effects on Solubility, Foaming and Emulsion Properties.

Enzymatic Deamidation of Plant Proteins by Protein-Glutamine Glutaminases: Effects on Solubility, Foaming and Emulsion Properties.

Journal: Foods (Basel, Switzerland)
Published: May 19, 2026

Secretory Production of Mature Protein-Glutaminase from Bacteroides helcogenes in Bacillus subtilis.

Secretory Production of Mature Protein-Glutaminase from Bacteroides helcogenes in Bacillus subtilis.

Journal: Applied biochemistry and biotechnology
Published: July 04, 2025

Toward food-grade production of the Bacteroides helcogenes protein-glutamine glutaminase with an optimized Bacillus subtilis strain.

Toward food-grade production of the Bacteroides helcogenes protein-glutamine glutaminase with an optimized Bacillus subtilis strain.

Journal: Applied microbiology and biotechnology
Published: June 14, 2025

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.

Journal: Molecular therapy. Nucleic acids
Published: June 28, 2024

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.

Journal: NPJ vaccines
Published: August 04, 2023

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.

Journal: Vaccines
Published: January 04, 2023

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.

Journal: NPJ vaccines
Published: July 15, 2022

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.

Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses.

Journal: Vaccines
Published: July 14, 2022

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models.

Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models.

Journal: Nature communications
Published: April 22, 2022

mRNA vaccines induce rapid antibody responses in mice.

mRNA vaccines induce rapid antibody responses in mice.

Journal: NPJ vaccines
Published: February 01, 2022

mRNA Vaccines Induce Rapid Antibody Responses in Mice.

mRNA Vaccines Induce Rapid Antibody Responses in Mice.

Journal: bioRxiv : the preprint server for biology
Published: November 09, 2021

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.

Journal: Nature
Published: August 13, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026